facebook
spears_logo

Top Recommended
Click to explore ranking

tatler_logo

Featured in
The Tatler Address Book

doctify_logo

Outstanding
Click to see reviews

spears_logo
tatler_logo
doctify_logo

Our Macular Oedema Prevention Protocol at Blue Fin Vision®

2 min read

Our CMO prevention protocol is built around three pillars: risk identification, targeted pharmacology and objective measurement.

Every cataract and lens replacement patient undergoes pre-operative macular OCT to detect occult pathology such as ERM or diabetic thickening. All patients then receive a combination of topical steroid and NSAID drops for at least six weeks after surgery, reflecting the period of highest inflammatory activity and the evidence from PREMED and meta-analyses.¹

High-risk eyes often continue treatment beyond six weeks when OCT or clinical findings justify it. Post-operatively we repeat macular OCT to look for subclinical thickening before vision is affected.²

If oedema appears, therapy is extended or intensified early. This structured approach allows us to align pharmacology with mechanism, tailor care to individual risk, and audit outcomes transparently over time.

References

  1. Wielders LHP, Schouten JSAG, Winkens B, et al. ESCRS PREMED Study Report 1. Ophthalmology. 2018;125(2):195-204.
  2. Chu CJ, Johnston RL, Buscombe C, et al. Risk factors and incidence of macular edema after cataract surgery. Ophthalmology. 2016;123(2):316-323.

Related Topics

Return to Knowledge Base

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.